Guggenheim Remains Bullish on Eli Lilly (LLY) Ahead of Q1 2026 Results
On March 30, 2026, Guggenheim updated its model ahead of the first-quarter data and lowered the firm’s price target for Eli Lilly and Company (NYSE:LLY) from $1,168 to $1,163, while keeping a “Buy...







